Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-15 Purchase(A) | 2025-01-17 2:30 pm | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 25,000 | $3.2599 | $81,499 | 476,897 (Direct) | View |
| 2025-01-15 Purchase | 2025-01-17 08:03 am | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 25,000 | $3.2599 | $81,499 | 476,897 (Direct) | View |
| 2024-12-10 Sale | 2024-12-12 6:00 pm | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 359,606 | $2.8461 | $1,023,475 | 451,897 (Direct) | View |
| 2024-09-17 Sale | 2024-09-19 8:02 pm | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 57,969 | $4.0393 | $234,155 | 5,982,582 (Indirect Direct) | View |
| 2024-06-20 Sale | 2024-06-21 5:59 pm | Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director | 17,544 | $3.4852 | $61,144 | 136,406 (Direct) | View |
| 2024-06-05 Sale | 2024-06-07 6:34 pm | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 1,006 | $4 | $4,024 | 6,040,551 (Indirect Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:31 pm | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 15,843 | $3.8449 | $60,915 | 958,941 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:30 pm | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 56,910 | $3.845 | $218,819 | 6,836,490 (Indirect Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:29 pm | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 15,870 | $3.8414 | $60,963 | 301,530 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:26 pm | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 12,477 | $3.8394 | $47,904 | 207,623 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:25 pm | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 11,819 | $3.843 | $45,420 | 303,489 (Indirect Direct) | View |
| 2024-02-01 Sale | 2024-02-02 9:24 pm | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 14,029 | $3.843 | $53,913 | 354,162 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-31 Option Award | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 211,250 | $0 | 339,438 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 14,134 | $3.06 | 339,438 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 46,800 | $0 | 339,438 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 141,550 | $0 | 309,472 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 11,517 | $3.06 | 309,472 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 33,333 | $0 | 309,472 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 202,550 | $0 | 304,959 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 16,071 | $3.06 | 304,959 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 41,533 | $0 | 304,959 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 210,500 | $0 | 972,173 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 16,102 | $3.06 | 972,173 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 44,367 | $0 | 972,173 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 639,035 | $0 | 6,879,949 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 88,601 | $3.06 | 6,879,949 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 173,467 | $0 | 6,879,949 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 128,100 | $0 | 211,561 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 12,062 | $3.06 | 211,561 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 33,333 | $0 | 211,561 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-21 6:12 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director | 70,800 | $0 | 70,800 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-21 6:08 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 70,800 | $0 | 70,800 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-21 6:06 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director | 70,800 | $0 | 70,800 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-21 6:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director | 70,800 | $0 | 70,800 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-21 5:59 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director | 70,800 | $0 | 136,406 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-21 5:54 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 70,800 | $0 | 70,800 (Direct) | View |
| 2024-06-16 Exercise | 2024-06-18 5:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 33,150 | $0 | 56,445 (Direct) | View |
| 2024-06-16 Exercise | 2024-06-18 5:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director | 33,150 | $0 | 83,150 (Direct) | View |
| 2024-06-16 Exercise | 2024-06-18 5:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 33,150 | $0 | 811,503 (Direct) | View |
| 2024-06-16 Exercise | 2024-06-18 5:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director | 33,150 | $0 | 83,150 (Direct) | View |
| 2024-06-16 Exercise | 2024-06-18 5:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director | 33,150 | $0 | 33,150 (Direct) | View |
| 2024-06-16 Exercise | 2024-06-18 5:00 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director | 33,150 | $0 | 33,150 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:31 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 200,000 | $0 | 958,941 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:31 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 44,367 | $0 | 958,941 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:30 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 448,000 | $0 | 6,836,490 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:30 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 173,467 | $0 | 6,836,490 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:29 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 192,800 | $0 | 301,530 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:29 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 41,534 | $0 | 301,530 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:26 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 120,100 | $0 | 207,623 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:26 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 33,334 | $0 | 207,623 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:25 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 132,800 | $0 | 303,489 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:25 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 33,334 | $0 | 303,489 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 9:24 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 225,200 | $0 | 354,162 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:24 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 46,800 | $0 | 354,162 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director | 79,900 | $0 | 79,900 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:38 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer | 240,000 | $0 | 240,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:35 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 299,100 | $0 | 299,100 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:33 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman | 1,249,000 | $0 | 1,249,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:30 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 319,400 | $0 | 319,400 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:28 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 337,000 | $0 | 337,000 (Direct) | View |